Development of cellular signaling pathway inhibitors as new antivirals against influenza
Author:
Funder
German FluResearchNet
German Ministry of Education and Research
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference107 articles.
1. The development of proteasome inhibitors as anticancer drugs;Adams;Cancer Cell,2004
2. The proteasome: a suitable antineoplastic target;Adams;Nat. Rev. Cancer,2004
3. Development of the proteasome inhibitor Velcade (Bortezomib);Adams;Cancer Invest.,2004
4. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers;Adjei;J. Clin. Oncol.,2008
5. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901;Barrett;Bioorg. Med. Chem. Lett.,2008
Cited by 85 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MEK inhibitors in oncology: a patent review and update (2016 - present);Expert Opinion on Therapeutic Patents;2024-09-14
2. Evaluation of the Antiviral Activity of Tabamide A and Its Structural Derivatives against Influenza Virus;International Journal of Molecular Sciences;2023-12-09
3. Neuroinflammation in the Evolution of Motor Function in Stroke and Trauma Patients: Treatment and Potential Biomarkers;Current Issues in Molecular Biology;2023-10-25
4. Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets;Nature Communications;2023-09-27
5. Artesunate inhibits PDE4 leading to intracellular cAMP accumulation, reduced ERK/MAPK signaling, and blockade of influenza A virus vRNP nuclear export;Antiviral Research;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3